Inspira Technologies Addresses Trade Policy Impact
Ticker: IINNW · Form: 6-K · Filed: Feb 10, 2025 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Feb 10, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $199.1 billion |
| Sentiment | neutral |
Sentiment: neutral
Topics: trade-policy, medical-devices, geopolitics
TL;DR
Inspira is watching US trade policy changes that could hit European medical device imports.
AI Summary
Inspira Technologies Oxy B.H.N. Ltd. commented on its strategic position on February 10, 2025, in response to potential U.S. trade policy changes impacting European imports. The company noted that in 2019, U.S. medical device spending was $199.1 billion, with European manufacturers contributing to this market.
Why It Matters
This filing indicates the company is monitoring geopolitical and trade developments that could affect its market access and competitive landscape in the U.S.
Risk Assessment
Risk Level: medium — Potential changes in U.S. trade policy can introduce uncertainty and affect international sales and supply chains.
Key Numbers
- $199.1B — U.S. Medical Device Spending (Represents market size in 2019, relevant to potential trade impacts.)
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant commenting on strategic position
- AdvaMed (company) — Cited for 2021 report on U.S. medical device spending
- $199.1 billion (dollar_amount) — Total U.S. medical device spending in 2019
FAQ
What specific U.S. trade policy changes is Inspira Technologies OXY B.H.N. Ltd. concerned about?
The filing mentions 'potential U.S. trade policy changes affecting European imports' but does not specify which particular changes are of concern.
What was the date of the AdvaMed report cited?
The AdvaMed report mentioned in the filing is from 2021.
What was the total U.S. medical device spending in 2019 according to the AdvaMed report?
According to the 2021 AdvaMed report, U.S. medical device spending totaled $199.1 billion in 2019.
Does Inspira Technologies OXY B.H.N. Ltd. file annual reports as a Form 20-F or Form 40-F?
Inspira Technologies OXY B.H.N. Ltd. files annual reports under cover of Form 20-F.
What is the principal executive office address for Inspira Technologies OXY B.H.N. Ltd.?
The principal executive office is located at 2 Ha-Tidhar St., Ra'anana 4366504, Israel.
Filing Stats: 610 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-02-10 06:36:02
Key Financial Figures
- $199.1 billion — d, U.S. medical device spending totaled $199.1 billion in 2019, representing 5.2% of total nat
Filing Documents
- ea0230491-6k_inspira.htm (6-K) — 12KB
- 0001213900-25-011479.txt ( ) — 13KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: February 10, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2